|
Aug 26
|
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
|
|
Jun 26
|
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
|
|
Apr 1
|
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript
|
|
Mar 25
|
Agile Therapeutics Announces Delisting from Nasdaq
|
|
Mar 24
|
12 Best Biotech Penny Stocks to Invest In
|
|
Mar 21
|
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
|
|
Mar 20
|
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
|
|
Mar 13
|
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
|
|
Jan 25
|
11 Hyper-Growth Stocks Billionaires Are Loading Up On
|
|
Jan 23
|
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
|
|
Nov 10
|
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
|
|
Nov 9
|
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Jul 3
|
This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
|
|
Jun 30
|
Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?
|
|
Jun 28
|
The Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Care
|
|
Apr 28
|
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
|
|
Apr 26
|
Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
|